Amphastar Pharmaceuticals, Inc. (AMPH) — Analysis Summary

Amphastar Pharmaceuticals, Inc. (AMPH) has a market cap of $977.99M with year-over-year revenue growth of +13.6%. Net margin stands at 21.8%. The stock trades at a P/E ratio of 6.1.

Key Takeaways

• Revenue changed +13.6% year-over-year
• Net margin of 21.8%
• P/E ratio of 6.1

Compared to other companies in the PHARMACEUTICAL PREPARATIONS sector, AMPH posted revenue growth of +13.6% and trades at a P/E of 6.1.